Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial
Titel:
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial
Auteur:
van den Bent, Martin J Klein, Martin Smits, Marion Reijneveld, Jaap C French, Pim J Clement, Paul de Vos, Filip Y F Wick, Antje Mulholland, Paul J Taphoorn, Martin J B Lewis, Joanne Weller, Michael Chinot, Olivier L Kros, Johan M de Heer, Iris Verschuere, Tina Coens, Corneel Golfinopoulos, Vassilis Gorlia, Thierry Idbaih, Ahmed